SAVINO, Rocco
 Distribuzione geografica
Continente #
NA - Nord America 1.513
EU - Europa 436
AS - Asia 29
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
SA - Sud America 4
Totale 1.993
Nazione #
US - Stati Uniti d'America 1.442
IT - Italia 197
SE - Svezia 114
CA - Canada 71
GB - Regno Unito 61
DE - Germania 30
IN - India 16
ES - Italia 7
RO - Romania 7
EU - Europa 6
AU - Australia 5
IR - Iran 4
CL - Cile 3
FR - Francia 3
RU - Federazione Russa 3
UA - Ucraina 3
IE - Irlanda 2
IL - Israele 2
JP - Giappone 2
NL - Olanda 2
TR - Turchia 2
AT - Austria 1
BG - Bulgaria 1
CN - Cina 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HK - Hong Kong 1
HR - Croazia 1
MD - Moldavia 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 1.993
Città #
Chandler 357
Princeton 134
Lawrence 130
Wilmington 79
Catanzaro 68
Ottawa 67
Ashburn 57
London 48
Des Moines 41
Chicago 40
Troina 27
Norwalk 15
Seattle 14
New York 13
Florence 12
Naples 12
Falls Church 11
Pune 9
Redmond 9
Ann Arbor 6
Boardman 6
Hanover 6
Parenti 5
Redwood City 5
Rome 5
Girona 4
Horia 4
Mountain View 4
Washington 4
West Jordan 4
Palermo 3
Vibo Valentia 3
Andover 2
Assago 2
Atlanta 2
Campbelltown 2
Esslingen am Neckar 2
Ferrara 2
Foggia 2
Novokuznetsk 2
Padova 2
Rende 2
Timisoara 2
Toronto 2
Verona 2
Aiello Calabro 1
Amsterdam 1
Augusta 1
Aversa 1
Berlin 1
Brierley Hill 1
Chisinau 1
Cupertino 1
Dublin 1
Elk Grove Village 1
Fayetteville 1
Frankfurt am Main 1
Galway 1
Ginowan 1
Hayward 1
Las Vegas 1
Leawood 1
Leipzig 1
Logan 1
Madrid 1
Melbourne 1
Nagold 1
Nizhnevartovsk 1
Oslo 1
Paola 1
Phoenix 1
Polistena 1
Quito 1
San Francisco 1
San Mateo 1
Saskatoon 1
Selargius 1
Settingiano 1
Sindelfingen 1
Sofia 1
Taipei 1
Tappahannock 1
Tokyo 1
Turin 1
Villeurbanne 1
Zagreb 1
Totale 1.269
Nome #
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 45
Application of proteomics and peptidomics to COPD 39
Asthma and COPD proteomics: Current approaches and future directions 38
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 34
MALDI MS-Based Investigations Targeting SARS-CoV-2 34
An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 32
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 31
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 29
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 27
Mesopore-assisted Profiling of Human Synovial Fluid 27
TLR4 triggered complex inflammation in human pancreatic islets 26
Integrating peptidomic with lipidomic fingerprints by using mesoporous aluminosilicate and MALDI-TOF MS 26
Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis 26
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 25
A rapid and reproducible standardized procedure for MALDI-TOF profiling of gingival crevicular fluid 25
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 25
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 23
REGULATION OF U3 SNRNA GENE-EXPRESSION 23
Generation of IL-6 antagonists by substituting residues in helix A 23
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 23
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 23
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 22
The molecular design of human IL-6 receptor antagonists 22
PRERIBOSOMAL RNA PROCESSING IN XENOPUS-OOCYTES DOES NOT INCLUDE CLEAVAGE WITHIN THE EXTERNAL TRANSCRIBED SPACER AS AN EARLY STEP 22
Treatment with an adenoviral vector expressing the IL-6 receptor superantagonist sant7 compared with the treatment with the recombinant sant7 protein in MM cell lines 22
Biochemical modification of an Interleukin-6 antagonist to target myeloma cells in the bone marrow microenvironment 22
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 22
Association between low bone mineral density and increased α-defensin in salivary fluid among postmenopausal women 22
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial 22
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 22
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 22
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 22
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 22
EXTRA-RIBOSOMAL SPACER SEQUENCES IN TRITURUS 21
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 21
Mesopore-assisted fingerprints of gingival crevicular fluid by MALDI-TOF mass spectrometry for monitoring inflammatory state in patients wearing fixed orthodontic appliance 21
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 21
Biologics in severe asthma 21
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 20
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 20
Peptidome profiling of gingival crevicular fluid by MALDI-TOF/TOF mass spectrometry 20
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 20
Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: tomato sauce and hypercholesterolemia 20
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 20
Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone 19
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 19
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung 19
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 19
Adenovirus-mediated gene transfer of a human IL-6 antagonist 19
Revealing the Hidden Diagnostic Clues of Male Infertility from Human Seminal Plasma by Dispersive Solid Phase Extraction and MALDI-TOF MS 18
An alternative approach for the identification of potential prostate cancer biomarkers 18
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 18
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1 17
Identification of residues critical for biological activity and receptor binding of human Interleukin-6 17
Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometry 17
ANTI-TUMOUR PHARMACEUTICAL COMPOSITIONS CAPABLE OF REDUCING DRUG RESISTANCE IN TUMOUR CELLS 17
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 17
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 17
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 17
A ROLE FOR U3 SMALL NUCLEAR RIBONUCLEOPROTEIN IN THE NUCLEOLUS 16
Mesoporous Beads: New Tools and Strategies in Body Fluids Proteomics 16
Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 16
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 16
Monovalent phage display of human Interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in hIL-6 D-helix 16
Effect of IL-6 variants in Multiple Myeloma:growth inhibition and induction of apoptosis in primary cells 15
C3f is a potential tool for the staging of osteoarthritis 15
Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization 15
Designing new agonists/antagonists of growth factor receptors- The rational design of a super-antagonist of the IL-6 receptor 14
Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector 14
Severe Eosinophilic Asthma: from the Pathogenic role of Interleukin-5 to the Therapeutic Action of Mepolizumab. 14
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 14
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu in vivo model of human multiple myeloma 14
Liposomal Delivery Improves the Growth Inhibitory and Apoptotic Activity of Low Doses of Gemcitabine in Multiple Myeloma Cancer Cells 14
A mass spectrometry-based proteomic approach for the identification and quantification of potential biomarkers in prostate cancer. 13
Combination of Interleukin-6 antagonists and antiproliferative drugs 13
Associazione di antagonisti di IL-6 e farmaci anti-proliferativi (depositato il 10.3.2005 n. RM2005A000103) 13
ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES 13
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 13
Designing new agonists/antagonists of growth factor receptors - rational design of a superantagonist of the IL-6 receptor 13
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells 13
Liquid Crystalline Phases for the Ophthalmic Administration of Drug 12
Simultaneous extraction and rapid visualization of peptidomic and lipidomic body fluids fingerprints using mesoporous aluminosilicate and MALDI-TOF MS. 12
MUTANT INTERLEUKIN 6 WITH IMPROVED BIOLOGICAL ACTIVITY OVER WILD INTERLEUKIN 6 12
Functionalized Mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine 12
An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus 12
Synergistic induction of growth arrest and apoptosis of human myeloma 11
Testosterone replacement therapy in insulin-sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism 11
test di Valutazione di efficacia dei chemioterapici effettuato su tre distinte e complementari popolazioni cellulari derivate dalla massa tumorale solida 10
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation 10
USE OF MUTEINS OF WILD-TYPE CYTOKINES AS IMMUNOGENS 10
Terapia Genica 10
MALDI MS-Based Investigations for SARS-CoV-2 Detection 10
277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 9
IL-6 mediates the effects of IL-1 or TNF, but not of PTHrP or 1,25 -(OH)2D3 on osteoclast-like cell formation in normal human bone marrow cultures 9
Definition of a complex binding site for gp130 in human interleukin-6 (IL-6) 9
Human Herpesvirus Type 8 (HHV-8) Interleukin-6 homologue is functionally active on human myeloma cells 9
Optimization of the Helper Dependent Adenovirus System for Production and Potency in vivo 9
MALDI-TOF MS ANALYSIS OF LOW-ABUNDANCE PEPTIDE ENRICHED FROM BODY FLUIDS BY MESOPOROUS SILICA BEADS 9
In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist 9
Derivatized Mesoporous Silica Beads for MALDI-TOF MS Profiling of Human Plasma and Urine 9
Totale 1.865
Categoria #
all - tutte 30.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020102 0 0 0 4 8 5 1 0 7 4 15 58
2020/2021191 17 3 1 3 7 2 3 5 136 8 0 6
2021/2022362 2 0 10 90 37 10 17 78 30 32 55 1
2022/20231.070 267 45 50 76 117 132 5 60 169 44 83 22
2023/2024366 63 59 54 22 26 100 4 24 5 7 2 0
Totale 2.091